Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure-activity relationships of pyrimidine-5-carboxamide derivatives (vol 13, pg 4936, 2005)

被引:2
|
作者
Hisamichi, H
Naito, R
Toyoshima, A
Kawano, N
Ichikawa, A
Orita, A
Orita, M
Hamada, N
Takeuchi, M
Ohta, M
Tsukamoto, S
机构
[1] Astellas Pharma Inc, Inst Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan
[2] Astellas Pharma Inc, Dept Clin Dev, Tokyo 1748612, Japan
关键词
D O I
10.1016/j.bmc.2005.08.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:6277 / 6279
页数:3
相关论文
共 50 条
  • [1] Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure-activity relationships of pyrimidine-5-carboxamide derivatives
    Hisamichi, H
    Naito, R
    Toyoshima, A
    Kawano, N
    Ichikawa, A
    Orita, A
    Orita, M
    Hamada, N
    Takeuchi, M
    Ohta, M
    Tsukamoto, SI
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (16) : 4936 - 4951
  • [2] Studies on scavenger receptor inhibitors. Part 1: Synthesis and structure-activity relationships of novel derivatives of sulfatides
    Yoshiizumi, K
    Nakajima, F
    Dobashi, R
    Nishimura, N
    Ikeda, S
    BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (08) : 2445 - 2460
  • [3] Synthesis and structure-activity relationships of novel IKK-β inhibitors.: Part 2:: Improvement of in vitro activity
    Murata, T
    Shimada, M
    Kadono, H
    Sakakibara, S
    Yoshino, T
    Masuda, T
    Shimazaki, M
    Shintani, T
    Fuchikami, K
    Bacon, KB
    Ziegelbauer, KB
    Lowinger, TB
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (15) : 4013 - 4017
  • [4] Novel Hepatitis C virus replicon inhibitors: Synthesis and structure-activity relationships of fused pyrimidine derivatives
    Krueger, A. Chris
    Madigan, Darold L.
    Beno, David W.
    Betebenner, David A.
    Carrick, Robert
    Green, Brian E.
    He, Wenping
    Liu, Dachun
    Maring, Clarence J.
    McDaniel, Keith F.
    Mo, Hongmei
    Molla, Akhteruzzaman
    Motter, Christopher E.
    Pilot-Matias, Tami J.
    Tufano, Michael D.
    Kempf, Dale J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (06) : 2212 - 2215
  • [5] 17,20-Lyase inhibitors. Part 3: Design, synthesis, and structure-activity relationships of biphenylylmethylimidazole derivatives as novel 17,20-lyase inhibitors
    Kaku, Tomohiro
    Tsujimoto, Saori
    Matsunaga, Nobuyuki
    Tanaka, Toshimasa
    Hara, Takahito
    Yamaoka, Masuo
    Kusaka, Masami
    Tasaka, Akihiro
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (07) : 2428 - 2442
  • [6] 17,20-Lyase inhibitors. Part 4: Design, synthesis and structure-activity relationships of naphthylmethylimidazole derivatives as novel 17,20-lyase inhibitors
    Kaku, Tomohiro
    Matsunaga, Nobuyuki
    Ojida, Akio
    Tanaka, Toshimasa
    Hara, Takahito
    Yamaoka, Masuo
    Kusaka, Masami
    Tasaka, Akihiro
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (05) : 1751 - 1770
  • [7] Phosphodiesterase inhibitors. Part 1: Synthesis and structure-activity relationships of pyrazolopyridine-pyridazinone PDE inhibitors developed from ibudilast
    Allcock, Robert W.
    Blakli, Haakon
    Jiang, Zhong
    Johnston, Karen A.
    Morgan, Keith M.
    Rosair, Georgina M.
    Iwase, Kazuhiko
    Kohno, Yasushi
    Adams, David R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (11) : 3307 - 3312
  • [8] Synthesis, structure-activity relationships, and mechanistic studies of 5-arylazo-tropolone derivatives as novel xanthine oxidase (XO) inhibitors
    Sato, Daisuke
    Kisen, Takuya
    Kumagai, Mina
    Ohta, Kiminori
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (02) : 536 - 542
  • [9] Synthesis and structure-activity relationships of novel IKK-β inhibitors.: Part 3:: Orally active anti-inflammatory agents
    Murata, T
    Shimada, M
    Sakakibara, S
    Yoshino, T
    Masuda, T
    Shintani, T
    Sato, H
    Koriyama, Y
    Fukushima, K
    Nunami, N
    Yamauchi, M
    Fuchikami, K
    Komura, H
    Watanabe, A
    Ziegelbauer, KB
    Bacon, KB
    Lowinger, TB
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (15) : 4019 - 4022
  • [10] Structure-activity relationship studies of imidazo[1,2-c] pyrimidine derivatives as potent and orally effective Syk family kinases inhibitors
    Hirabayashi, Akihito
    Mukaiyama, Harunobu
    Kobayashi, Hiroaki
    Shiohara, Hiroaki
    Nakayama, Satoko
    Ozawa, Motoyasu
    Tsuji, Eiichi
    Miyazawa, Keiji
    Misawa, Keiko
    Ohnota, Hideki
    Isaji, Masayuki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (20) : 9247 - 9260